Haim Biran

1.1k total citations
40 papers, 841 citations indexed

About

Haim Biran is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Haim Biran has authored 40 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 12 papers in Epidemiology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Haim Biran's work include Neuroendocrine Tumor Research Advances (11 papers), Lung Cancer Research Studies (10 papers) and Lung Cancer Treatments and Mutations (7 papers). Haim Biran is often cited by papers focused on Neuroendocrine Tumor Research Advances (11 papers), Lung Cancer Research Studies (10 papers) and Lung Cancer Treatments and Mutations (7 papers). Haim Biran collaborates with scholars based in Israel, United States and Canada. Haim Biran's co-authors include Michael Glantz, Tamar Peretz, Benjamin Nisman, S. Clifford Schold, Henry Furneaux, Kurt A. Jaeckle, Shirley H. Wray, Jerome B. Posner, Marc K. Rosenblum and Martin Lesser and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Neurology.

In The Last Decade

Haim Biran

39 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haim Biran Israel 15 277 260 200 149 129 40 841
F. Cardenal Spain 11 222 0.8× 199 0.8× 337 1.7× 204 1.4× 45 0.3× 21 696
Peter Kießling Germany 19 307 1.1× 232 0.9× 120 0.6× 196 1.3× 324 2.5× 40 1.9k
Gabriele Jaques Germany 19 126 0.5× 609 2.3× 360 1.8× 131 0.9× 71 0.6× 40 1.1k
James N. Gerson United States 10 374 1.4× 236 0.9× 123 0.6× 68 0.5× 86 0.7× 16 636
Fritz Lampert Germany 20 396 1.4× 787 3.0× 237 1.2× 77 0.5× 212 1.6× 52 1.8k
Elvis Terci Valera Brazil 18 227 0.8× 725 2.8× 275 1.4× 144 1.0× 86 0.7× 108 1.4k
George E. Sanborn United States 21 236 0.9× 276 1.1× 142 0.7× 104 0.7× 101 0.8× 56 1.8k
John E. Neely United States 13 283 1.0× 376 1.4× 199 1.0× 203 1.4× 75 0.6× 18 895
Kirsten van Lom Netherlands 25 153 0.6× 539 2.1× 326 1.6× 114 0.8× 75 0.6× 47 1.5k
Nicolas U. Gerber Switzerland 17 361 1.3× 620 2.4× 138 0.7× 204 1.4× 45 0.3× 63 1.3k

Countries citing papers authored by Haim Biran

Since Specialization
Citations

This map shows the geographic impact of Haim Biran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haim Biran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haim Biran more than expected).

Fields of papers citing papers by Haim Biran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haim Biran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haim Biran. The network helps show where Haim Biran may publish in the future.

Co-authorship network of co-authors of Haim Biran

This figure shows the co-authorship network connecting the top 25 collaborators of Haim Biran. A scholar is included among the top collaborators of Haim Biran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haim Biran. Haim Biran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nisman, Benjamin, Hovav Nechushtan, Haim Biran, et al.. (2016). New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer. British Journal of Cancer. 114(4). 469–476. 17 indexed citations
2.
Sella, Tal, et al.. (2015). Preferences for disclosure of disease related information among thoracic cancer patients. Lung Cancer. 88(1). 100–103. 4 indexed citations
3.
Bar, Jair, Nir Peled, Haim Biran, et al.. (2015). A single-arm phase II study of afatinib treatment for advanced EGFR-mutant non-small cell lung cancer (mNSCLC) patients (pts) with EGFR-tyrosine kinase inhibitor (TKI) resistance.. Journal of Clinical Oncology. 33(15_suppl). e19031–e19031. 2 indexed citations
4.
Bar, Jair, Arnold Cyjon, Dov Flex, et al.. (2014). EGFR Mutation Testing Practice in Advanced Non-Small Cell Lung Cancer. Lung. 192(5). 759–763. 5 indexed citations
5.
6.
Idelevich, Efraim, et al.. (2006). Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer. Acta Oncologica. 46(3). 324–329. 5 indexed citations
7.
Merimsky, Ofer, Rony Weitzen, Tamar Peretz, et al.. (2004). Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2. Annals of Oncology. 15(4). 610–612. 22 indexed citations
8.
Zalel, Y., et al.. (1998). Unsuspected uterine leiomyosarcoma discovered during treatment with a gonadotropin-releasing hormone analogue: A case report and literature review. European Journal of Obstetrics & Gynecology and Reproductive Biology. 76(2). 237–240. 21 indexed citations
9.
Cibien, C., et al.. (1995). Seasonal diet and habitat use in field roe deer (Capreolus capreolus) in the Picardie region. HAL (Le Centre pour la Communication Scientifique Directe). 4 indexed citations
10.
Glantz, Michael, Haim Biran, Mark E. Myers, Jon P. Gockerman, & Marc H. Friedberg. (1994). The radiographic diagnosis and treatment of paraneoplastic central nervous system disease. Cancer. 73(1). 168–175. 23 indexed citations
11.
Dgani, R., Y. Zalel, Haim Biran, et al.. (1994). Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen. European Journal of Obstetrics & Gynecology and Reproductive Biology. 54(1). 77–79. 2 indexed citations
12.
Ariel, I., Calvin E. Oyer, Michael Elkin, et al.. (1994). Relaxation of Imprinting in Trophoblastic Disease. Gynecologic Oncology. 53(2). 212–219. 44 indexed citations
13.
Biran, Haim, I. Ariel, Natalia Sánchez de Groot, & Abraham Hochberg. (1994). On the oncodevelopmental role of human imprinted genes. Medical Hypotheses. 43(2). 119–123. 5 indexed citations
14.
Biran, Haim, Ilana Ariel, Nathan de Groot, Adi Shani, & Abraham Hochberg. (1994). Human Imprinted Genes as Oncodevelopmental Markers. Tumor Biology. 15(3). 123–134. 31 indexed citations
15.
Furneaux, Henry, Marc K. Rosenblum, Shirley H. Wray, et al.. (1991). Anti‐Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer. Annals of Neurology. 29(3). 241–251. 279 indexed citations
16.
17.
Biran, Haim, R. Feld, Uri Sagman, et al.. (1989). Carcinoembryonic Antigen, Arginine Vasopressin and Calcitonin as Markers of Early Small-Cell Lung Cancer Relapse. Tumor Biology. 10(5). 258–267. 8 indexed citations
18.
Buskila, Dan, et al.. (1988). Exposure of cryptantigens on erythrocytes in patients with breast cancer. Cancer. 61(12). 2455–2459. 4 indexed citations
19.
Biran, Haim, Joel L. Moake, Jordan U. Gutterman, et al.. (1976). Complement activation in vivo in cancer patients receiving C. parvum immunotherapy. British Journal of Cancer. 34(5). 493–499. 8 indexed citations
20.
Biran, Haim, John M. Stern, & A. Dvilansky. (1972). Impaired platelet aggregation after Echis colorata bite in man.. PubMed. 8(10). 1757–1757. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Cardenal Breakdown of academic impact, for papers by Peter Kießling Breakdown of academic impact, for papers by Gabriele Jaques Breakdown of academic impact, for papers by James N. Gerson Breakdown of academic impact, for papers by Fritz Lampert Breakdown of academic impact, for papers by Elvis Terci Valera Breakdown of academic impact, for papers by George E. Sanborn Breakdown of academic impact, for papers by John E. Neely Breakdown of academic impact, for papers by Kirsten van Lom Breakdown of academic impact, for papers by Nicolas U. Gerber
Rankless by CCL
2026